The aCGH process begins with isolating DNA from both the cancerous and normal tissues. These DNA samples are then labeled with different fluorescent dyes. The labeled DNA is hybridized to a microarray containing probes that represent the entire genome. By measuring the fluorescence intensity, researchers can determine the relative copy number of DNA segments in the cancer cells compared to normal cells.
